Kinetics of Antibody Response to Repeated Vaccination with Sputnik V: A Pilot Study with a Series of Five Cases.
COVID-19
SARS-COV-2
Sputnik V vaccine
antibody
immunoassay
Journal
EJIFCC
ISSN: 1650-3414
Titre abrégé: EJIFCC
Pays: Italy
ID NLM: 101092742
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
1
11
2022
Statut:
epublish
Résumé
Widespread vaccination is considered as one of the best methods in combating any pandemic including COVID-19. Gam-COVID-Vac also known as Sputnik V, is one of the first vaccines that was registered in 74 countries and received an emergency approval for immunization. Monitoring anti-SARS-CoV-2 antibodies over time is essential for evaluation of post-vaccination humoral immune response.To date, there are only a limited number of clinical studies regarding the analysis of immune response after Sputnik V administration. It is of crucial importance to report independently on safety and efficiency of this vaccine with the aim to speed up the process of its final approval by the WHO. Humoral immune response was monitored by seven immunoassays to analyze different classes of anti-SARS-CoV-2 Ig in five health workers after receiving the combined vector vaccination. This vaccine is based on two replication-deficient rAd26 and rAd5 viral vectors that carry the gene SARS-CoV-2 full-length glycoprotein S(rAd26-S and rAd5-S). Sputnik V was administered with a 21-day interval between the first and second dose. Venous blood was collected two hours before vaccination as a baseline, and then followed by 18 series up to 170-day post-vaccination. The participants in this study used a self-report form in which they noted their observations on safety at 72 h post-immunization. One participant reported mild side effects, such as muscle pain and fever, while the other four individuals had no noticeable complications. Seroconversion was detected in all individuals at 28 days of post-vaccination. Plateau of seropositivity has been achieved by 50th day of vaccination, while titer values decreased after 6 months. This study provides some clinical data regarding the kinetics of antibody levels elicited after administration of heterologous rAd26-S and rAd5-S vaccine. Based on the preliminary data from this pilot study, it appears that Sputnik V vaccine generates a solid humoral immune response lasting at least 6 months after immunization.
Types de publication
Journal Article
Langues
eng
Pagination
175-186Informations de copyright
Copyright © 2022 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):719-724
pubmed: 33988185
Cell Rep Med. 2021 Aug 17;2(8):100359
pubmed: 34308389
Clin Microbiol Infect. 2020 Oct;26(10):1386-1394
pubmed: 32603801
Stem Cell Res. 2020 Dec 15;50:102125
pubmed: 33341604
N Engl J Med. 2021 Jun 10;384(23):2259-2261
pubmed: 33822494
Nat Commun. 2022 Jan 25;13(1):482
pubmed: 35079022
J Infect. 2022 May;84(5):675-683
pubmed: 34990709
Nature. 2021 Jul;595(7867):339-340
pubmed: 34230663
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
Front Immunol. 2019 Jan 15;9:3064
pubmed: 30697210
Lancet. 2021 Feb 20;397(10275):671-681
pubmed: 33545094
Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
Lancet Reg Health Eur. 2021 Dec;11:100241
pubmed: 34746910
Medicina (B Aires). 2021;81(3):408-414
pubmed: 34137701
J Infect. 2021 Aug;83(2):e4-e5
pubmed: 34214516
Nature. 2022 Jan;601(7893):312-315
pubmed: 35042997
Int J Infect Dis. 2021 Oct;111:261-266
pubmed: 34343704
Science. 2020 Jun 26;368(6498):1422-1424
pubmed: 32461212
J Med Biochem. 2021 Sep 03;40(4):327-334
pubmed: 34616222
Vaccines (Basel). 2014 Jul 29;2(3):624-41
pubmed: 26344749
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
EBioMedicine. 2020 Dec;62:103101
pubmed: 33160207
Lancet. 2021 Mar 13;397(10278):952-954
pubmed: 33581803